Lockjaw (tetanus) - Symptoms, Causes, Treatment & Prevention

```html

Overview

Tetanus, commonly called lockjaw, is a serious bacterial infection that affects the nervous system and causes painful muscle spasms, most often beginning with the jaw. The disease is caused by Clostridium tetani, an anaerobic, spore‑forming bacterium that produces a potent neurotoxin (tetanospasmin). The toxin interferes with normal neurotransmission, leading to unopposed muscle contraction.

Although tetanus can occur at any age, it is most common in adults who have not been fully immunized or who have waning immunity. In the United States, approximately 30 cases are reported each year, while worldwide the World Health Organization (WHO) estimates 30,000–50,000 deaths annually—most in low‑income countries where vaccination coverage is lower (WHO, 2023).

Symptoms

The incubation period (time from exposure to first symptom) is usually 3–21 days, with a median of 8 days. Symptoms progress in a characteristic pattern:

• Trismus (lockjaw): Inability to open the mouth fully; pain on jaw movement.
• Spasms of neck and facial muscles: “Risus sardonicus” – a fixed, grin‑like expression.
• Difficulty swallowing (dysphagia): May lead to drooling.
• Generalized muscle rigidity: Neck stiffness, torso arching (opisthotonus).
• Painful muscle cramps: Often triggered by sudden noise, touch, or light.
• Autonomic dysfunction: Sweating, fever, hypertension, tachycardia, or rapid breathing.
• Seizure‑like activity: In severe cases, seizures can occur secondary to hypoxia.
• Respiratory compromise: Paralysis of the diaphragm or intercostal muscles can cause breathing difficulty.

Symptoms usually appear in the same area as the wound that introduced the spores, but the toxin spreads systemically, leading to generalized involvement.

Causes and Risk Factors

Primary cause

Clostridium tetani spores are ubiquitous in soil, dust, animal intestines, and manure. When spores enter a break in the skin—especially a deep or puncture wound—an anaerobic environment allows them to germinate and produce toxin.

Key risk factors

• Incomplete or outdated tetanus immunization: Immunity wanes after 10 years; boosters are recommended every decade.
• Puncture or contaminated wounds: Nail‑store injuries, animal bites, crush injuries, burns, or surgical incisions.
• Injection drug use: Sharing needles can introduce spores.
• Age: Infants (<6 months) and the elderly have higher morbidity due to weaker immune responses.
• Chronic diseases: Diabetes, peripheral vascular disease, or immunosuppression increase susceptibility.
• Occupational exposure: Farmers, gardeners, construction workers, and veterinarians are at higher exposure risk.

Diagnosis

Because tetanus is a clinical diagnosis, physicians rely on history and physical examination. Laboratory tests are adjunctive.

Clinical assessment

• History of a recent wound (often < 48 h to 2 weeks prior).
• Absence of other explanations for muscle rigidity.
• Typical signs – trismus, opisthotonus, generalized spasm.

Supportive tests

• Wound culture: Rarely yields C. tetani because the organism is difficult to grow; negative cultures do not rule out disease.
• Serum tetanus antitoxin level: May be measured in research settings, but not needed for acute care.
• Imaging (X‑ray, CT): Used to assess wound depth or foreign bodies, not the infection itself.
• Electrocardiogram (ECG): Monitors autonomic instability.

Given the rapid progression and high mortality, treatment is initiated based on suspicion rather than waiting for confirmatory tests.

Treatment Options

Management requires a multidisciplinary approach: eradication of the source, neutralization of unbound toxin, control of muscle spasms, and supportive care.

1. Immediate wound care

• Thorough irrigation and debridement of necrotic tissue.
• Removal of any foreign bodies.

2. Antitoxin (human tetanus immune globulin – TIG)

• Neutralizes toxin not yet bound to nerve tissue.
• Recommended dose: 3000–6000 IU intramuscularly, administered as soon as possible.
• Contraindicated in patients with a severe IgA deficiency; monitor for allergic reactions.

3. Antibiotics

• Metronidazole 500 mg IV/PO q6h (preferred) – penetrates anaerobic tissue and reduces bacterial load.
• Alternative: Penicillin G 2–4 million U IV q4‑6h, though metronidazole is associated with fewer seizures.

4. Control of muscle spasm

• Diazepam 5–10 mg IV q1‑2h (or continuous infusion) – first‑line for spasm control.
• Adjuncts: baclofen, dantrolene, or phenobarbital for refractory spasms.

5. Supportive care

• Intensive care unit (ICU) monitoring for airway protection; mechanical ventilation if respiratory muscles are compromised.
• Sedation and analgesia to minimize stimulus‑induced spasms.
• Fluid and electrolyte management; treat fever with antipyretics.
• Passive range‑of‑motion exercises to prevent contractures.

6. Immunization

• Even after recovery, give tetanus toxoid vaccine (Td or Tdap) at a different anatomical site than the TIG injection.

Living with Lockjaw (tetanus)

Survivors may face lingering effects, especially muscle stiffness or joint contractures. Practical strategies include:

• Physical therapy: Gentle stretching 2–3 times daily to maintain mobility.
• Occupational therapy: Adaptive devices (e.g., modified utensils) for activities of daily living.
• Pain management: NSAIDs or low‑dose muscle relaxants as prescribed.
• Nutrition: Soft or pureed foods during the acute phase; progress to regular diet as jaw opening improves.
• Psychological support: Anxiety related to muscle spasms is common; counseling or support groups can be beneficial.
• Vaccination follow‑up: Ensure boosters are up‑to‑date; keep an immunization record.

Prevention

Vaccination is the cornerstone of tetanus prevention.

• Routine schedule: Five-dose series in childhood (DTaP), followed by Td or Tdap booster every 10 years.
• Wound management: Clean all cuts, punctures, or burns promptly. For high‑risk wounds, give a tetanus booster if the last dose was >5 years ago.
• Safe animal handling: Wear gloves when dealing with livestock or soil; wash hands thoroughly.
• Travel precautions: Ensure up‑to‑date tetanus vaccination before travel to regions with low coverage.
• Education: Public health campaigns in high‑risk occupations have reduced incidence by up to 70 % in some countries (CDC, 2022).

Complications

If untreated, tetanus can be fatal. Potential complications include:

• Respiratory failure: Due to diaphragmatic paralysis; the leading cause of death.
• Cardiovascular instability: Arrhythmias, hypertension, or hypotension from autonomic dysfunction.
• Fractures: Forceful muscle spasms can cause bone breaks, especially in the ribs and spine.
• Secondary infections: Necrotic wound may become infected with other bacteria.
• Prolonged hospitalization: ICU stay may last weeks, increasing risk of nosocomial complications.
• Long‑term neurologic deficits: Persistent muscle weakness, joint contractures, or chronic pain.

When to Seek Emergency Care

References

• Mayo Clinic. Tetanus. 2023. https://www.mayoclinic.org
• Centers for Disease Control and Prevention (CDC). Prevention of Tetanus, Diphtheria, and Pertussis. 2022. https://www.cdc.gov
• World Health Organization. Tetanus Fact Sheet. 2023. https://www.who.int
• National Institutes of Health (NIH). Clostridium tetani and Tetanus Toxin. 2021. NCBI Bookshelf
• Cleveland Clinic. Tetanus (Lockjaw) – Symptoms, Diagnosis & Treatment. 2022. https://my.clevelandclinic.org

```